Oaktree Acquisition Corp. III Life Sciences (OACCW)
US — Financial Services Sector
Automate Your Wheel Strategy on OACCW
With Tiblio's Option Bot, you can configure your own wheel strategy including OACCW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OACCW
- Rev/Share 0.0
- Book/Share 9.9504
- PB -2.7012
- Debt/Equity 0.0
- CurrentRatio 1.3948
- ROIC -0.0014
- MktCap 22759469.0
- FreeCF/Share -0.0069
- PFCF -172.4228
- PE 5.5722
- Debt/Assets 0.0
- DivYield 0
- ROE -0.4855
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 4
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Oaktree Acquisition Corp. III Life Sciences (OACCW)
- IPO Date 2025-10-06
- Website https://www.oaktreeacquisitioncorp.com/oac-iii
- Industry Shell Companies
- CEO Zaid Pardesi
- Employees None
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.